Adverse Event Reporting
| VAERS ID | 942602 |
|---|---|
| Gender | Male |
| Age | 53 |
| StateCode | NJ |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | EK9231 |
| Number of vaccinations | 2 |
| Vaccinated | 2021-01-05 |
| Onset | 2021-01-01 |
| Condition | Permanent Disability |
Symptoms
- Fatigue
- Pain in extremity
- Headache
- Hyperhidrosis
- Tremor
- Pain
- Injection site pain
- Feeling of body temperature change
- Condition aggravated
- Myalgia
- Migraine
- SARS-CoV-2 test negative
- Sleep disorder
Current Illness
Preexisting Conditions
Medical History/Concurrent Conditions: Airways obstruction; Blood pressure abnormal; Kidney stone; Migraine (he has other family members with history of migraines.)
Other Medications
VITAMIN D [COLECALCIFEROL]; ; ; VALSARTAN & HCTZ; ADVAIR;
Previous Vaccinations
Allergies
Laboratory Data
Test Name: COVID test; Result Unstructured Data: Test Result:Negative; Comments: He had a nasopharyngeal COVID test and it was negative; Test Name: COVID test; Result Unstructured Data: Test Result:Negative; Comments: There is a combination of saliva oropharyngeal and immunoglobins.
He has been negative multiple times.
; Test Name: Weight; Result Unstructured Data: Test Result:250 to 255 lbs; Comments: Weight: 250 to 255 pounds
Write-up
Headache; migraine; tenderness at injection site; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias; Fatigue; This is a spontaneous report from a contactable physician (patient).
A 53-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on right deltoid on 05Jan2021 07:45 at single dose for covid-19 immunization.
Family history included migraine (other family members).
Medical history included mild blood pressure and kidney stones, reactive airway disease.
Concomitant medication included colecalciferol (VITAMIN D), potassium, allopurinol and hydrochlorothiazide/valsartan for mild blood pressure and kidney stones, fluticasone propionate, salmeterol xinafoate (ADVAIR) for reactive airway disease, atorvastatin, and multivitamins.
The patient previously took fluticasone propionate, salmeterol xinafoate (ADVAIR) and experienced dry mouth and lost sense of taste.
The patient also previously took Tdap booster on Aug2020, Shingrix on 10Aug2020, and influenza on 12Oct2020; all for immunization; and tetanus injections for immunization and experienced localized tenderness.
The patient had the first dose of BNT162B2 (lot number: EH9899) for COVID-19 immunization on 15Dec2020 and experienced localized tenderness at injection point.
The received his second dose of COVID vaccine on 05Jan2021.
With the first dose he had increased localized tenderness at injection site on 15Dec2020, and he rated it mild to moderate.
He would say it was 80% resolved in 24 hours.
It had completely resolved in 36 hours.
He would say that he has recovered completely form the localized tenderness with the first dose.
Then he noted his second dose was yesterday, in the context of not having much sleep the night before.
The actual injection was uncommonly eerily painless.
The other folks in his department had similar experience.
Maybe it was the nurse who gave the injection.
Maybe it was because it was the same area and sensitivity was decreased.
They had to check the Band-Aid to make sure blood was there.
The administration was painless.
He was relieved when the arm started getting sore to know he actually received it.
He had increased arm tenderness at injection site which he rated as moderate which has now resolved.
It got to moderate where lifting the arm up was sore.
He definitely knew that he had been vaccinated.
He got the vaccine at 7:45AM and now it is 16 to 17 hours later and he would say the pain is mild now.
It did persist.
The first vaccine hurt a little more.
He expects this to go away.
Ten hours after injection he had shaking, sweats, hot and cold flashes, and augmentation of myalgias.
He had unrelenting headache over night that was moderate to severe.
He said it kept him awake.
It was exacerbated by lying down.
Sitting up helped him.
It became a migraine which is something he doesn't often experience.
Migraines are pretty rare for him.
He took 800mg of Advil at 6AM that helped for headache and migraine.
The weight of the patient was 250 to 255 pounds.
Shaking, sweats, hot and cold flashes, and augmentation of myalgias have resolved.
Everything has resolved except for a little headache.
In the background he literally had one or two hours of sleep.
He thinks that likely precipitated a migraine was increased.
Last night he slept literally an hour.
He took 800mg of Advil and fell asleep.
He is operating on 2 hours of sleep in 48 hours.
Most of the stuff is gone except a little headache and expected fatigue.
Headache Seriousness Criteria: he would say that it was relatively disabling.
He would not have been able to carry on.
He wouldn't have been able to operate last night.
It would have interfered.
It was dissimilar to others.
He gets rare migraines.
Everything was amplified with a migraine.
He certainly felt that.
It was fair to say the vaccine precipitated the migraine that was mild or severe.
He doesn't want to falsely attribute these things to the vaccine.
Causality Headache: precipitated by the vaccine.
In the context that he had not slept the night before.
He had a nasopharyngeal COVID test and it was negative.
He has been in a COVID study where they are looking at combination.
They developed a saliva test at (Name).
There is a combination of saliva oropharyngeal and immunoglobins.
He has been negative multiple times.
The outcome of the events headache and fatigue was not recovered and recovered for the rest of the events.
; Sender's Comments: A causal association between BNT162B2 and the reported event headache cannot be excluded based on a compatible temporal relation between vaccination and onset of events.
The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events.
Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to RAs, Ethics Committees, and Investigators, as appropriate.